Showing results (491-500 of 502) with videos related to

Sort By:
Pageof 51
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and TherapeuticsDeyin Xing, Gang Zheng, Aparna Pallavajjala, et al.
Mbio|October 4, 2023
Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojectorShiwen Peng, Hsin-Fang Tu, Michelle Cheng, et al.
Clinical Pharmacology and Therapeutics|December 31, 2010
Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory reviewP Zhao, L Zhang, J A Grillo, et al.
American Journal of Clinical Pathology|January 29, 2013
A broad survey of cathepsin K immunoreactivity in human neoplasmsGang Zheng, Guido Martignoni, Cristina Antonescu, et al.
AIDS Research and Therapy|December 31, 2022
Effects of syphilis infection among HIV-1-positive individuals on suppressive antiretroviral therapyPhillip Chan, Tommy H C Tang, Ruby T S Kwong, et al.
Oncoimmunology|October 6, 2018
A novel function of API5 (apoptosis inhibitor 5), TLR4-dependent activation of antigen presenting cellsYoung Seob Kim, Hyun Jin Park, Jung Hwa Park, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 4, 2014
Enhancement of tumor-specific T cell-mediated immunity in dendritic cell-based vaccines by Mycobacterium tuberculosis heat shock protein XIn Duk Jung, Sung Jae Shin, Min-Goo Lee, et al.
Advanced Healthcare Materials|December 17, 2013
Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growthMing Yang, Tao Yu, Ying-Ying Wang, et al.
Cancer Research|July 19, 2017
HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor CellsKwon-Ho Song, Chel Hun Choi, Hyo-Jung Lee, et al.
Gynecologic Oncology|August 21, 2025
A randomized pilot study of HPV16 L2E7E6 fusion protein vaccination site post-treatment for HPV16+ cervical cancerStéphanie Gaillard, Jade Alvarez, Tianbei Zhang, et al.
Pageof 51